Literature DB >> 11418627

Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients.

V Racanelli1, D Sansonno, C Piccoli, F P D'Amore, F A Tucci, F Dammacco.   

Abstract

PCR DNA amplification of IgH genes was performed on liver biopsy samples of 42 unselected hepatitis C virus (HCV)-positive patients. Genotypic analysis and signal amplification by branched DNA were used to characterize and quantitate HCV RNA genomic sequences. Intraportal lymphoid follicle-like structures were isolated from surrounding hepatocytes by microdissection technique. IgH VDJ PCR products were cloned and sequenced. IgH VDJ gene rearrangements were detected in the liver of 26 (62%) patients. Unequivocal monoclonal or oligoclonal patterns of B cell expansions were found in 14 (33.3%) and 12 (28.6%) patients, respectively. Patients with intrahepatic B cell monoclonal expansions showed liver HCV RNA levels higher than those with oligoclonal or polyclonal features (1106.4 +/- 593.5 vs 677.3 +/- 424.3 vs 406.2 +/- 354.3 pg HCV RNA/g tissue; p = 0.048 and p = 0.001, respectively). Although a single dominant band was obtained with total DNA, characterization of DNA recovered from intraportal inflammatory aggregates resulted in the detection of multiple IgH VDJ gene rearrangements, pointing to an oligoclonal pattern of lymphoproliferation. Cloning and sequence analyses showed that B cell clonalities were differently distributed in adjacent portal tracts of the same liver area. In addition, HCV RNA genomic sequences could be consistently amplified from each of the portal inflammatory aggregates examined. These data support the concept that in chronic HCV infection the intrahepatic B cell repertoire is frequently clonally restricted and that HCV may have a direct role in sustaining in situ B cell proliferation.

Entities:  

Mesh:

Year:  2001        PMID: 11418627     DOI: 10.4049/jimmunol.167.1.21

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  The analysis and quantification of a clonal B cell response in a hyperimmunized anti-D donor.

Authors:  S E Dohmen; O J H M Verhagen; S M de Groot; L M Stott; R C Aalberse; S J Urbaniak; C E van der Schoot
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Cryoglobulins in chronic hepatitis C virus infection.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 3.  Hepatitis C virus and lymphoma.

Authors:  D S Viswanatha; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

4.  Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; M Montrone; F A Tucci; L Nisi; F Dammacco
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.

Authors:  Carlo Selmi; Angela Ceribelli; John M Vierling
Journal:  Semin Immunopathol       Date:  2012-12-19       Impact factor: 9.623

6.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

Review 7.  Role of hepatitis C virus in B cell lymphoproliferations.

Authors:  Felicia Tucci; Ralf Küppers
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

8.  Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.

Authors:  Ana Henriques; Arancha Rodríguez-Caballero; Ignacio Criado; Anton W Langerak; Wendy G Nieto; Quentin Lécrevisse; Marcos González; Emília Cortesão; Artur Paiva; Julia Almeida; Alberto Orfao
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

Review 9.  Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.

Authors:  Lynn B Dustin; Edgar D Charles
Journal:  Antivir Ther       Date:  2012-12-07

10.  Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; L Nisi; P Gatti; F Pesola; N Pansini; F Dammacco
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.